Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


O.O. Solodovnikova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An infographic model of a database for conducting an analytical study of the long-term consequences of cervical cancer treatment

    by Ye.B. Radzishevska, О.м. Sukhina, L.Ya. Vasylyev, V.S. Sukhin, К.V. Nemaltsova, O.O. Solodovnikova

    Relevance. The development of ideas of critical attitude to medical information led to the concepts of evidence-based medicine (EM) in the late 1980s. The main postulates of EM are following: – every doctor’s decision must be based on scientific data; – the weight of each fact is greater, the stricter the method of scientific research in the course of which it was obtained. Correct planning of the research design and qualified statistical analysis are the most important for obtaining reliable, scientifically based results. The application of modern information technologies to arrays of catamnetic data of patients with cervical cancer (CRC) provides an opportunity to conduct a scientific study on the detection of the dependence of the appearance of oncological consequences of CRC treatment (metastases, relapses, secondary cancers) and manifestations of radiation toxicity on the clinical and biological characteristics of the patient and the features of the performed chemoradiation treatment. A necessary component of the success of such research is strict adherence to the principles of evidence-based medicine at all stages, in particular research planning. The main task at this stage is to determine the informative constitutional and biological, biometric, and social characteristics of the patient, parameters of treatment and the development of the disease in order to create a relevant informational model of the research database. The purpose of the work is to create an infological model of the catamnetic database of patients with CRC in order to determine the risk factors of local and distant metastasis and radiation toxicity during radical chemoradiation treatment of patients with CRC. Materials and methods: scientific literature with a level of evidence of primary data not lower than 2+, analysis of own experience, specialized analytical system «Database of patients». Results and discussion. An infological model of the database of catamnetic data of patients with CRC has been created, which provides the most complete representation of the subject area, contains all the entities and their attributes necessary for implementation. It is shown which parameters, factors and features of the disease should be taken into account when creating a database to obtain informationally significant results based on the accumulated data. Conclusions. The relevant informational model of the research database created in accordance with the approaches of evidence-based medicine is a necessary component for obtaining scientifically based results based on the catamnetic data of patients with CRC. Актуальність. Розвиток ідей критичної оцінки медичної інформації привів до виникнення наприкінці 80-х років XX століття концепції доказової медицини (ДМ). Основними постулатами ДМ є такі: – кожне рішення лікаря має ґрунтуватися на наукових даних; – вага кожного факту тим більше, чим суворіше методика наукового дослідження, у процесі якого він отриманий. Правильне планування структури дослідження і грамотний статистичний аналіз, з погляду ДМ, є найбільш важливими для отримання надійних, науково обґрунтованих результатів. Застосування сучасних інформаційних технологій до масивів катамнестичних даних хворих на рак шийки матки (РШМ) надає можливість провести наукове дослідження щодо виявлення залежності появи онкологічних наслідків лікування РШМ (метастази, рецидиви, вторинні раки) і проявів променевої токсичності від клініко-біологічних характеристик пацієнта та особливостей проведеного хіміопроменевого лікування. Необхідною складовою успіху такого дослідження є неухильне дотримання принципів доказової медицини на всіх етапах його проведення, зокрема планування дослідження. Стосовно проблеми, що вирішується, основним завданням планування є визначення інформативних конституційнобіологічних біометричних, соціальних характеристик пацієнта, параметрів лікування та перебігу захворювання для створення релевантної інфологічної моделі бази даних дослідження. Мета роботи – створити інфологічну модель бази катамнестичних даних для визначення факторів ризику локального і віддаленого метастазування й променевої токсичності при радикальному хіміопроменевому лікуванні хворих на РШМ. Матеріали та методи. Літературні джерела за рівнем доведеності первинних даних не нижче за 2+, аналіз власного досвіду, спеціалізована аналітична система «База даних хворих». Результати та їх обговорення. Створено...


  • Open Access

    Treatment strategy and clinical characteristics of patients with cervical cancer as prognostic parameters of survival

    by Ye.B. Radzishevska, О.м. Sukhina, L.YA. Vasylyev, V.S. Sukhin, К.V. Nemaltsova, H.V. Kulinich, O.O. Solodovnikova, Є.б. Радзішевська, Л.я. Васильєв, Г.в. Кулініч

    Background. Cervical cancer (CRC) ranks second in the world among all malignant neoplasms of the female genital organs. According to the WHO, more than 500000 new cases of CRC are detected annually in the world. In 2021, 3398 new cases of the disease were registered in Ukraine. Currently a number of factors that have a rather high individual prognostic significance influences the CRC development. Among these factors are those which are associated with an adverse outcome: heavy hereditary anamnesis, growth form of tumor and its localization, variant of spread, depth of invasion into the stroma, morphological structure, methods of treatment, etc. Over the last decade, there has been an unfavorable trend towards an increase in the number of young patients who have an advanced tumor process, which significantly restricts methods and reduces the chances of the successful treatment. Thereby, the high level of morbidity and mortality from CRC, especially among young patients, as well as the unsatisfactory results of 5-year survival after traditional methods of treatment, indicate that the cancer of this type is the prior problem in domestic oncology. Purpose. To make scientific analysis of modern treatment strategies and characteristics of CRC as prognostic survival parameters. Materials and methods. The literature review included available full-text publications, which were obtained as a result of an in-depth analysis of foreign and domestic scientific publications. Results. Authors gave analysis of modern domestic and foreign literature on the evaluation of the effectiveness of treatment of cervical cancer patients; namely, how treatment strategies, individual characteristics of patients and characteristics of the tumor affect the results of treatment and prognosis of patient survival. It is shown which parameters, factors and important nuances of the disease should be taken into account, which is decisive in choosing treatment tactics and preventing complications. Conclusions. Knowing and taking into account the prognostic parameters of the survival of cervical cancer patients is important for the assessment of treatment standards, as well as the development of personalized tactics for the treatment and monitoring of this disease.


  • Open Access

    Assessing the influence of special treatment of differentiated thyroid cancer on the urinary system long-term effects

    by L.YA. Vasyliev, Ye.B. Radzishevska, A.S. Savchenko, H.V. Kulinich, O.O. Solodovnikova, Л.я. Васильєв, Є.б. Радзішевська, Г.в. Кулініч

    Background. Differentiated thyroid cancer (DTC) is the most common endocrine tumour. Its prevalence varies from 1.0% to 2.2% of all malignant neoplasms. The standard strategy of special treatment of DTC consists of surgery, radionuclide therapy and hormone therapy being sequentially applied. Theoretically, each component of the treatment process can cause adverse somatic consequences in future, the study of which can help to prevent and correct them. Purpose – to evaluate possible long-term effects of the treatment of differentiated thyroid cancer in the form of the urinary system (US) pathologies on the basis of follow-up data of long-term observation using sophisticated information technologies. Materials and methods. The study was based on follow-up data of 157 individuals who were undergoing combination treatment of DTC at the Institute clinic from 1993 to 2015, received it in full and underwent regular screening examinations after treatment. The database created for the study contained, as much as possible, digitized arrays of follow-up data of paper case-records on the disease and its consequences in patients with a follow-up period exceeding 1 year after special treatment. The number of logical records of long-term consequences in the generated database was 463 units – one record for one type of long-term consequences of each of 157 patients. Statistical processing of data was carried out in two ways: comparing the incidence of US pathologies before treatment and at a long time after special treatment and identifying factors of statistically significant influence on the occurrence of US pathologies among the treatment peculiarities. WizWhy packages (Data Mining category) and the general purpose software package STATISTICA were used to make hypotheses and test them. Results and discussion. The analysis of the available references has shown that there is only a limited number of papers dealing with the US status of DTC patients. However, a comprehensive analysis of the long-term consequences of treatment of DTC patients revealed a statistically significant increase of US disease cases within the period of 3.75 – 4.8 years after special treatment. It was shown that the total number of US pathologies was 2.04 times higher in comparison with US incidence before the oncet of special treatment. These differences did not depend on age: the median for age of patients before treatment was 51 years, after treatment – 50 years. Additionally, it has been found that patients with or without episodes of postoperative hypothyroidism decompensation with a dose of L-thyroxine not exceeding 2.5 μg/kg need special attention due to the occurrence of urolithiasis. The obtained dependences are quite predictable, since, firstly, it is known that thyroid hormones affect kidney development and physiology, and secondly, the major percent of 131I in radioiodine therapy is excreted with the urine and deposited in the bladder, that can result in a radio-induced carcinogenic effect. Conclusions. Special treatment of DTC increases US pathologies more than twice. The term of post-treatment pathologies is 2.5 (3.75 – 4.8) years. Patients who have episodes of postoperative hypothyroidism during hormone therapy with a dose of L-thyroxine not exceeding 2.5 μg / kg represent the high-risk group.